Role for c-mpl and its ligand thrombopoietin in early hematopoiesis

Naoyuki Katayama, Ryugo Itoh, Takashi Kato, Takayuki Sugawara, Nadim Mahmud, Kohshi Ohishi, Masahiro Masuya, Masatoshi Aoki, Nobuyuki Minami, Hiroshi Miyazaki, Hiroshi Shiku

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Proto-oncogene c-mpl is structurally homologous with the hematopoietic growth factor receptor superfamily. The ligand for c-mpl was purified and its gene cloned. Extensive functional studies revealed that the ligand for c-mpl plays a crucial role in megakaryocytopoiesis and platelet production, hence, this ligand proved to be the long-sought hematopoietin, thrombopoietin (TPO). We briefly review here the role for TPO in early hematopoiesis, based on our in vitro data obtained using a serum-free culture system. TPO in combination with the ligand for c-kit (SF) or interleukin-3 (IL-3) but not TPO alone supported the growth of murine primitive hematopoietic progenitors. Studies on lineage expression indicated that the progenitors supported by TPO plus SF or TPO plus IL-3 are multipotential. Delayed addition experiments demonstrated that TPO has the potential to effectively support the survival of primitive hematopoietic progenitors. TPO also hastened IL-3-dependent growth of progenitors by shortening the time required for cell-cycling. While size of the colonies did not differ between colonies supported by IL-3 alone and those supported by IL-3 plus TPO, the incidence of megakaryocyte-containing colonies in cultures supported by IL-3 plus TPO was higher than that in cultures supported by IL-3 alone. Taken together, TPO as a single factor can support the survival of hematopoietic progenitors and TPO synergizes with SF or IL-3 to be active on early multipotential hematopoietic progenitors. These findings suggest that the function of TPO initially thought to be restricted to the megakaryocytic lineage proved to be greater in hematopoiesis. Reports from other laboratories regarding the involvement of TPO in early hematopoiesis are also discussed.

Original languageEnglish
Pages (from-to)51-56
Number of pages6
JournalLeukemia and Lymphoma
Volume28
Issue number1-2
Publication statusPublished - 1997
Externally publishedYes

Fingerprint

Thrombopoietin
Hematopoiesis
Interleukin-3
Hematopoietic Cell Growth Factors
Colony-Stimulating Factor Receptors
Thrombopoiesis
Stem Cell Factor
Megakaryocytes
Proto-Oncogenes

Keywords

  • C-mpl
  • C-mpl ligand
  • Early hematopoiesis

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Katayama, N., Itoh, R., Kato, T., Sugawara, T., Mahmud, N., Ohishi, K., ... Shiku, H. (1997). Role for c-mpl and its ligand thrombopoietin in early hematopoiesis. Leukemia and Lymphoma, 28(1-2), 51-56.

Role for c-mpl and its ligand thrombopoietin in early hematopoiesis. / Katayama, Naoyuki; Itoh, Ryugo; Kato, Takashi; Sugawara, Takayuki; Mahmud, Nadim; Ohishi, Kohshi; Masuya, Masahiro; Aoki, Masatoshi; Minami, Nobuyuki; Miyazaki, Hiroshi; Shiku, Hiroshi.

In: Leukemia and Lymphoma, Vol. 28, No. 1-2, 1997, p. 51-56.

Research output: Contribution to journalArticle

Katayama, N, Itoh, R, Kato, T, Sugawara, T, Mahmud, N, Ohishi, K, Masuya, M, Aoki, M, Minami, N, Miyazaki, H & Shiku, H 1997, 'Role for c-mpl and its ligand thrombopoietin in early hematopoiesis', Leukemia and Lymphoma, vol. 28, no. 1-2, pp. 51-56.
Katayama N, Itoh R, Kato T, Sugawara T, Mahmud N, Ohishi K et al. Role for c-mpl and its ligand thrombopoietin in early hematopoiesis. Leukemia and Lymphoma. 1997;28(1-2):51-56.
Katayama, Naoyuki ; Itoh, Ryugo ; Kato, Takashi ; Sugawara, Takayuki ; Mahmud, Nadim ; Ohishi, Kohshi ; Masuya, Masahiro ; Aoki, Masatoshi ; Minami, Nobuyuki ; Miyazaki, Hiroshi ; Shiku, Hiroshi. / Role for c-mpl and its ligand thrombopoietin in early hematopoiesis. In: Leukemia and Lymphoma. 1997 ; Vol. 28, No. 1-2. pp. 51-56.
@article{bbd5e8965246484196232278dadf2676,
title = "Role for c-mpl and its ligand thrombopoietin in early hematopoiesis",
abstract = "Proto-oncogene c-mpl is structurally homologous with the hematopoietic growth factor receptor superfamily. The ligand for c-mpl was purified and its gene cloned. Extensive functional studies revealed that the ligand for c-mpl plays a crucial role in megakaryocytopoiesis and platelet production, hence, this ligand proved to be the long-sought hematopoietin, thrombopoietin (TPO). We briefly review here the role for TPO in early hematopoiesis, based on our in vitro data obtained using a serum-free culture system. TPO in combination with the ligand for c-kit (SF) or interleukin-3 (IL-3) but not TPO alone supported the growth of murine primitive hematopoietic progenitors. Studies on lineage expression indicated that the progenitors supported by TPO plus SF or TPO plus IL-3 are multipotential. Delayed addition experiments demonstrated that TPO has the potential to effectively support the survival of primitive hematopoietic progenitors. TPO also hastened IL-3-dependent growth of progenitors by shortening the time required for cell-cycling. While size of the colonies did not differ between colonies supported by IL-3 alone and those supported by IL-3 plus TPO, the incidence of megakaryocyte-containing colonies in cultures supported by IL-3 plus TPO was higher than that in cultures supported by IL-3 alone. Taken together, TPO as a single factor can support the survival of hematopoietic progenitors and TPO synergizes with SF or IL-3 to be active on early multipotential hematopoietic progenitors. These findings suggest that the function of TPO initially thought to be restricted to the megakaryocytic lineage proved to be greater in hematopoiesis. Reports from other laboratories regarding the involvement of TPO in early hematopoiesis are also discussed.",
keywords = "C-mpl, C-mpl ligand, Early hematopoiesis",
author = "Naoyuki Katayama and Ryugo Itoh and Takashi Kato and Takayuki Sugawara and Nadim Mahmud and Kohshi Ohishi and Masahiro Masuya and Masatoshi Aoki and Nobuyuki Minami and Hiroshi Miyazaki and Hiroshi Shiku",
year = "1997",
language = "English",
volume = "28",
pages = "51--56",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "1-2",

}

TY - JOUR

T1 - Role for c-mpl and its ligand thrombopoietin in early hematopoiesis

AU - Katayama, Naoyuki

AU - Itoh, Ryugo

AU - Kato, Takashi

AU - Sugawara, Takayuki

AU - Mahmud, Nadim

AU - Ohishi, Kohshi

AU - Masuya, Masahiro

AU - Aoki, Masatoshi

AU - Minami, Nobuyuki

AU - Miyazaki, Hiroshi

AU - Shiku, Hiroshi

PY - 1997

Y1 - 1997

N2 - Proto-oncogene c-mpl is structurally homologous with the hematopoietic growth factor receptor superfamily. The ligand for c-mpl was purified and its gene cloned. Extensive functional studies revealed that the ligand for c-mpl plays a crucial role in megakaryocytopoiesis and platelet production, hence, this ligand proved to be the long-sought hematopoietin, thrombopoietin (TPO). We briefly review here the role for TPO in early hematopoiesis, based on our in vitro data obtained using a serum-free culture system. TPO in combination with the ligand for c-kit (SF) or interleukin-3 (IL-3) but not TPO alone supported the growth of murine primitive hematopoietic progenitors. Studies on lineage expression indicated that the progenitors supported by TPO plus SF or TPO plus IL-3 are multipotential. Delayed addition experiments demonstrated that TPO has the potential to effectively support the survival of primitive hematopoietic progenitors. TPO also hastened IL-3-dependent growth of progenitors by shortening the time required for cell-cycling. While size of the colonies did not differ between colonies supported by IL-3 alone and those supported by IL-3 plus TPO, the incidence of megakaryocyte-containing colonies in cultures supported by IL-3 plus TPO was higher than that in cultures supported by IL-3 alone. Taken together, TPO as a single factor can support the survival of hematopoietic progenitors and TPO synergizes with SF or IL-3 to be active on early multipotential hematopoietic progenitors. These findings suggest that the function of TPO initially thought to be restricted to the megakaryocytic lineage proved to be greater in hematopoiesis. Reports from other laboratories regarding the involvement of TPO in early hematopoiesis are also discussed.

AB - Proto-oncogene c-mpl is structurally homologous with the hematopoietic growth factor receptor superfamily. The ligand for c-mpl was purified and its gene cloned. Extensive functional studies revealed that the ligand for c-mpl plays a crucial role in megakaryocytopoiesis and platelet production, hence, this ligand proved to be the long-sought hematopoietin, thrombopoietin (TPO). We briefly review here the role for TPO in early hematopoiesis, based on our in vitro data obtained using a serum-free culture system. TPO in combination with the ligand for c-kit (SF) or interleukin-3 (IL-3) but not TPO alone supported the growth of murine primitive hematopoietic progenitors. Studies on lineage expression indicated that the progenitors supported by TPO plus SF or TPO plus IL-3 are multipotential. Delayed addition experiments demonstrated that TPO has the potential to effectively support the survival of primitive hematopoietic progenitors. TPO also hastened IL-3-dependent growth of progenitors by shortening the time required for cell-cycling. While size of the colonies did not differ between colonies supported by IL-3 alone and those supported by IL-3 plus TPO, the incidence of megakaryocyte-containing colonies in cultures supported by IL-3 plus TPO was higher than that in cultures supported by IL-3 alone. Taken together, TPO as a single factor can support the survival of hematopoietic progenitors and TPO synergizes with SF or IL-3 to be active on early multipotential hematopoietic progenitors. These findings suggest that the function of TPO initially thought to be restricted to the megakaryocytic lineage proved to be greater in hematopoiesis. Reports from other laboratories regarding the involvement of TPO in early hematopoiesis are also discussed.

KW - C-mpl

KW - C-mpl ligand

KW - Early hematopoiesis

UR - http://www.scopus.com/inward/record.url?scp=6844259867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=6844259867&partnerID=8YFLogxK

M3 - Article

C2 - 9498703

AN - SCOPUS:6844259867

VL - 28

SP - 51

EP - 56

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 1-2

ER -